A patient-centered, combination intervention to support adherence to HIV pre-exposure prophylaxis during pregnancy and breastfeeding: a randomized pilot study in Malawi
The intervention was integrated Next Step Counseling to identify relevant needs and help participants generate their own solutions for improving, facilitating, and sustaining well-being, sexual health, and drug adherence, as well as optional engagement of an adherence supporter. Study retention remained high at both three months and six months after initiation. There were no significant differences of adherence between the intervention group and control groups at three months or six months. Fewer than 1/3 of participants had confirmed adherence of >=4 doses/week.
Resource Details
- Study Type
- Pilot study, Randomized clinical trial (RCT)
- Year
- 2024
- Population
- HIV-uninfected women, Pregnant Women
- Author
- Chi BH, Saidi F, Graybill LA, Phanga T, Mollan KR, Amico KR, Freeborn K, Rosenberg NE, Hill LM, Hamoonga T, Richardson B, Kalua T, Phiri S, Mutale W.
More Publications & Resources
Standard Operating Procedure for Injectable Lenacapavir as Pre-exposure Prophylaxis
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Site/Facility Readiness Assessment Tool to Support Lenacapavir for HIV Prevention Introduction
Rapid Landscape Analysis of National Vertical Transmission Policies for Inclusion of PrEP for Pregnant and Breastfeeding People
Tools for Active Safety Surveillance of Maternal and Infant Health Outcomes for Pregnant and Breastfeeding Users of Oral PrEP and PrEP Ring
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions
Assessment of Facility Readiness for PrEP Provision in Antenatal and Postnatal Care Services
Oral PrEP for PBFP Training Package
Key Considerations for Integration of PrEP for Pregnant and Breastfeeding People into National Prevention of Vertical Transmission Polices
No results found.